Skip to main content
. 2022 Feb 9;14(2):381. doi: 10.3390/pharmaceutics14020381
aMSCs Animal Mesenchymal Stem/Stromal Cells;
ATMPs Advanced Therapies Medicinal Products;
bFBF Basic fibroblast growth factors
CCR Chemokine receptors
CM Conditioned medium
CD Cluster of differentiation
COX2 Cyclooxygenase 2
CXCL Chemokine ligand
CXCR Chemokine receptors
DC Dendritic Cells;
EGF Epidermal Growth Factor
EMA European Medicine Agency;
EV Extracellular Vesicles
FasL Fas Ligand
FDA Food and Drug Administration;
FGFR Fibroblast growth factor receptors
HCAM Homing Cell Adhesion Molecule
HCT/Ps Human Cellular and Tissue-based Products;
HGF Hepatocyte growth Factor
HLA Human Leucocyte Antigen
HLA-G Human Leucocyte Antigen G;
hMSCs Human Mesenchymal Stem/Stromal Cells;
ICAM Intercellular Adhesion Molecule
IDO Indoleamine 2, 3-dioxygenase
IFN Interferon
IGF insulin-like growth factor
IL Interleukin
iNOS Inducible nitric oxide synthase
ISCT International Society for Cellular Therapy
KGF Keratinocyte Growth Factor
LPS Lipopolysaccharides
miRNA MicroRNA
MMP Metalloproteinases
MSCs Mesenchymal Stem/Stromal Cells;
NK Natural Killers;
NO Nitric oxide
PCL Phospholipase
PDGF Platelet-derived growth factor
PD-L Programmed death-ligand
PD Programmed death
PGE Prostaglandins E
PSGL P-selectin glycoprotein ligand
ROS Reactive Oxygen Species
SDF Stromal cell-derived factor
TGF Transforming Growth Factor
TGF Transforming Growth Factor
TIMP Tissue inhibitors of metalloproteinases
TLR Toll-like receptors
TNF Tumor Necrosis Factor
Treg Regulatory T Lymphocytes
VCAM Vascular Cell Adhesion Molecule
VEGF Endothelial growth factor
VLA Very Late Antigen